Scientific Research For Plant Cultivation

Scientific Research For Plant Cultivation

Scientific research for plant cultivation with George Hodgin CEO of Biopharmaceutical Research Company. Our next guest is a graduate of the Stanford Graduate School of Business, a former Navy SEAL Officer and the CEO of Biopharmaceutical Research Company. This past August, the federal government announced it would begin processing dozens of pending applications for permission to cultivate the plant for scientific research. The U.S. Drug Enforcement Administration’s decision comes after several years of delay for some applicants and a lawsuit filed against the agency by one cannabis researcher.

Scientific Research

The U.S. Court of Appeals for the District of Columbia Circuit dismissed a lawsuit filed in June by the Scottsdale Research Institute that claimed the DEA was hampering federally approved marijuana studies by stalling cannabis cultivation applications. Led by Dr. Sue Sisley, the Scottsdale Research Institute had hoped that the lawsuit would force the U.S. Attorney General and the DEA to process its application to grow marijuana for clinical research. Biopharmaceutical Research Company’s cannabis cultivation application is pending, so research materials will be acquired through DEA channels. The company plans to begin cultivation for research after receiving authorization from the DEA.